As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them
Around the world, patients suddenly can’t find enough of the insulins made by companies they…
Category: Alternative Health News
STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund
Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from…
STAT+: Applesauce lead contamination could not have been prevented, top FDA officials says
CHICAGO – The FDA’s top food regulator contended Tuesday that the agency could not have…
STAT+: Early data from Lexeo’s gene therapy for rare heart disease shows promise
Lexeo Therapeutics said Monday that a gene therapy designed to prevent fatal cardiac complications of…
STAT+: Top FDA officials weighing regulation of ultra-processed foods, internal documents show
WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to…
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout…
STAT+: Pfizer says it will advance once-daily GLP-1 pill after all
Pfizer said that it plans to advance a new once-a-day formulation of its experimental obesity…
Medicaid is paying millions for salty, fat-laden ‘medically tailored’ cheeseburgers and sandwiches
WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of…
STAT+: Novo Nordisk’s weekly insulin rejected by FDA
The Food and Drug Administration rejected Novo Nordisk’s weekly insulin for the treatment of diabetes…
Lilly’s obesity drug looks more potent than Novo’s in observational study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: First Opinion readers respond to psychiatry and social contracts, Medicare and weight loss meds, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
GLP-1s lower risk of 10 obesity-associated cancers, study shows
New research found that the GLP-1 class of drugs — glucagon-like peptide receptor agonists —…
Opinion: My stalled relay race to get access to ALS drugs in development
One night in November 2018, I fell while crossing a street in Subic Bay, a…
Opinion: President Biden must take a cognitive screening test. Voters deserve to know the results
In the aftermath of President Biden’s debate with former President Trump last week, many of…
Study links Ozempic to higher risk of eye condition that can cause vision loss
A new observational study on Wednesday reported for the first time a potential link between…
.jpg)
After Biden debate performance, experts reflect on difference between ‘normal aging’ and something more
In the days after Thursday’s presidential debate, one of the questions that was asked on…
Q&A: The U.S. is losing control of hypertension. China’s ‘village doctors’ have lessons
The U.S. has slid backward on control of high blood pressure, despite ready access to…
Opinion: Medicare should wait on approving coverage for new obesity drugs
My dad, Randy, a 72-year-old retired sales manager, started to gain weight after grad school,…
.jpg)
Opinion: Congress called for an ALS moonshot. The plan for it doesn’t leave Earth
The National Academies of Sciences, Engineering, and Medicine recently released a congressionally mandated report on…
STAT+: Vape makers see Supreme Court ruling as a weapon in fighting FDA
WASHINGTON — Vape manufacturers are taking a victory lap over a Supreme Court decision that…
GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use
The ongoing shortage of glucagon-like peptide 1 receptor (GLP-1) agonists such as semaglutide (marketed as…
Opinion: Medicare’s Part D policy is blocking progress needed to achieve Black health equity
A new and effective class of anti-obesity medicines, along with lifestyle interventions and sometimes bariatric…
House panel passes bills to expand Medicare obesity drug coverage, cancer screening
WASHINGTON — A House committee overwhelmingly passed four bills on Thursday that would expand Medicare…
Listen: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? And what health…
Early Glaucoma Detection Is the Key to Sight-Saving Treatment
Glaucoma is often referred to as the “silent thief of sight” because it progresses slowly…
Frontline: Heart disease risk in women; reduce heart disease risk; tau protein and Alzheimer’s disease
Sex-Specific Criteria Help Predict Heart Disease Risk in Women Cardiovascular disease in women is often…
Precision Medicine Personalizes Treatment
In the rapidly evolving landscape of modern health care, precision medicine stands out as a…
Your Genetic Profile: A Guide to Disease Prevention and Treatment
Precision medicine is a type of health care that involves basing a patient’s treatment on…
Adopt Healthy Sleep Habits to Prevent Chronic Disease
Once in a while it’s normal to have difficulty falling asleep because you have a…
Hormone Replacement Therapy May Be Less Risky Than You Think
Hormone therapy (HT) works well to ease common menopause symptoms such as hot flashes, night…
Exercises That Improve Balance Reduce Falls and Boost Confidence
Falls are the leading cause of injuries among older adults, according to the Centers for…
Ask Dr. Etingin: Calcium scoring test; Lyme Disease
I have a family history of fatal heart attacks, hypertension, and high cholesterol. My cardiologist…
Four Tips for a Healthy Fourth
The Fourth of July is a perfect time for outdoor celebrations. Grilled burgers, hotdogs, chips,…
Newsbites: Stroke prevention; grazing vs. three meals; impact of ultraprocessed foods; walking for heart health.
Data Suggest Any Activity is Better Than None for Stroke Prevention The results of a…
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
WASHINGTON — As weight loss medications have exploded in popularity, a bill to allow Medicare…
Minimizing Dementia Caregiver Burnout
In the 1960s, the Peace Corps created a public service campaign with the slogan: “It’s…
Exercise Is a Natural Sleep Aid
Do you struggle to fall asleep at night? Do you wake up and find it…
News Briefs July 2024
Cannabis Use Linked to Higher Heart Attack and Stroke Risk A study published in the…
Do Home Microbiome Tests Help Support Your Gut?
A growing number of home microbiome test kits come with big promises for what they…
Plant-Based Diet Not Linked to Hip Fracture
Long term consumption of a plant-based diet (lower or no intake of animal foods) was…
Ask the EN Experts July 2024
Got a sweet tooth? Use caution—too much sugar can wreak havoc on health, especially as…
Opinion: CNN debate moderators could provide the cognitive tests that Biden and Trump have been avoiding
The two primary contenders for the presidency of the United States — President Joe Biden…
Standalone organ donor centers have sprouted all over the U.S. Do they work better than hospitals?
Not much sets the world of transplant medicine abuzz. But in the early 2000s, a…
STAT+: AliveCor gets FDA nod for portable 12-lead, AI-powered ECG device
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology….
Despite risks, aspirin use remains high among older adults
New research shows that, in spite of recommendations discouraging use of aspirin in primary prevention…
STAT+: Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval
Alnylam Pharmaceuticals said Monday that its treatment for an increasingly common heart condition cut the…
STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes
ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem…
‘We’re failing right now’ in type 2 diabetes, FDA chief says
ORLANDO — The United States is at a critical juncture in its efforts to treat…
Screen early in pregnancy for gestational diabetes, new Lancet series urges
Gestational diabetes affects one in seven expecting women globally and rates of this troubling condition…
Listen: Fauci’s memoir, Alnylam’s tenuous trial, and a mid-year review
Can Alnylam find success with its latest cardiac treatment after tweaking the trial? And did…